@ecgandrhythmRoe In this case, the drug challenge induced a type 2 or 3 pattern, which does not appear to be a type 1 pattern sufficient to establish the diagnosis.
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure: @NEJM @ESCCongress
🥸 Is evidence still in favor of beta blockers post AMI? #ESCCongress2025
😱Summary
👇👇👇
2025 ESC/EACTS Guidelines for the
management of valvular heart disease: @ESC_Journals
🥸Few highlights - dense document, please read full document for details.
😱 Summary
👇👇👇
La @uacardio_ccvu comparte tema libre y caso clínico en #ESC2025 representada por residentes Agustina Pérez y Ramiro Nin. Experiencia académica trascendental ,que los proyecta a ser excelentes profesionales. Compartir, enseñar y aprender es un ciclo sin fin. Felicitaciones!
Hypertensive emergencies can shred organs. Patients can present with various clinical manifestations. As much as we may want to make the numbers pretty immediately, we may need to show restraint. Here's how to do it. 🎩 tip to the authors.
https://t.co/Sfr6vCn6le
Abro hilo ordenando de PEOR a MEJOR las camisetas de local de los 32 equipos que jugarán el Mundial de Clubes.
Como siempre: opinión y gusto PERSONAL.
Vamos. 👇
Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update: @JACCJournals
🥸Commentary on the guidelines - early beta blocker use post MI -
😱@MichaelGNanna wrote extensively on this in older pts.
🥸Take a look
👇👇👇